By activating these two incretin hormones, tirzepatide offers a more comprehensive approach to managing blood sugar levels compared to other medications in its class
Xin Lu, orcid.org/0000-0003-1036-3369 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Does one genetic test cover the whole category
Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
